综合性疹病毒抗病毒药物耐药性突变数据库 (CHARMD)
Valentin Tilloy1, Daniel Díaz-González2, Lisa Laplace3
1Centre National de Référence des Herpèsvirus, CHU Limoges, Limoges, France; UF9481 Bioinformatique, CHU Limoges, Limoges, France; UF8843 Génomique médicale, CHU Limoges, Limoges, France; Inserm, U1092, RESINFIT, Université de Limoges, Limoges, France.
Antiviral research
|September 30, 2024
概括
一个新的疹病毒耐药性数据库为诊断和研究病毒突变提供了国际参考. 这种开源工具有助于研究人员标准化疹病毒的耐药性基因型.
科学领域:
- 病毒学 病毒学
- 遗传学 遗传学 是一个
- 生物信息学是一种生物信息学.
背景情况:
- 由于耐药性,疹病毒在临床管理中带来了重大挑战.
- 追踪耐药性突变的标准化资源对于有效的治疗和诊断至关重要.
研究的目的:
- 引入一个全面的,可访问的数据库,用于疹病毒耐药性.
- 为疹病毒突变分析和耐药性基因型定型的标准化建立国际参考标准.
主要方法:
- 开发一个在线数据库 (https://www.unilim.fr/cnr-herpesvirus/outils/codexmv/),对抗性突变和多态性进行编目.
- 包括来自人类细胞巨乳病毒的数据,并计划扩展到简单疹病毒和疹病毒.
- 设立一个国际委员会,审查和验证新的突变数据.
主要成果:
- 该数据库整合了疹病毒的耐药性突变和自然多态性.
- 它旨在与疹病毒序列分析 (HSA) 工具一起工作,用于分析下一代测序 (NGS) 和桑格序列.
- 该资源作为研究社区的开源平台.
结论:
- 疹病毒耐药性数据库解决了该领域的关键未满足需求.
- 它促进了耐药性基因定型的开发和标准化,以改善疹病毒管理.
- 该数据库促进了国际合作和参考实验室和研究人员之间的数据共享.
相关概念视频
Viral Mutations
32.2K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.2K
Retrovirus Life Cycles
45.7K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


